ANTIBODY TO LEPTIN RECEPTOR
    1.
    发明申请

    公开(公告)号:US20220275097A1

    公开(公告)日:2022-09-01

    申请号:US17623792

    申请日:2019-07-02

    Abstract: The present technology relates generally to compositions and methods of preventing or treating diseases associated with mutantleptin receptors, leptin deficiency or leptin dysfunction. The present technology also relates to administering the anti-leptin receptor antibodies in effective amounts to treat a subject suffering from, or predisposed to, a disease associated with mutant leptin receptors, obesity, leptin deficiency, leptin resistance, and/or hypoleptinemia.

Patent Agency Ranking